CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-17 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $1.18 | $18K | 333,122 |
| 2021-05-21 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $1.63 | $16K | 318,122 |
| 2021-05-19 | RAMSAY DAVID A Director | Purchase | +5,003 | $1.58 | $8K | 866,800 |
| 2021-05-18 | RAMSAY DAVID A Director | Purchase | +50,000 | $1.62 | $81K | 861,797 |
| 2021-05-17 | Chowdhury Badrul A. CHIEF MEDICAL OFFICER | Sale | −50,000 | $1.56 | $78K | 150,000 |
| 2021-05-15 | Chowdhury Badrul A. CHIEF MEDICAL OFFICER | Exercise or conversion | +200,000 | 200,000 | ||
| 2021-05-15 | Chowdhury Badrul A. CHIEF MEDICAL OFFICER | Exercise or conversion · Restricted Stock Units | −200,000 | 0 | ||
| 2021-04-19 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +27,400 | $1.82 | $50K | 308,122 |
| 2021-03-22 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +24,100 | $2.07 | $50K | 280,722 |
| 2021-03-15 | Lowrance David L CHIEF FINANCIAL OFFICER | Purchase | +13,793 | $1.45 | $20K | 13,793 |
| 2021-03-15 | McCracken Joseph S Director | Purchase | +68,965 | $1.45 | $100K | 168,337 |
| 2021-03-15 | RAMSAY DAVID A Director | Purchase | +689,655 | $1.45 | $1000K | 811,797 |
| 2021-02-22 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Purchase | +28,700 | $1.74 | $50K | 256,622 |
| 2020-12-16 | Lowrance David L CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +260,000 | 260,000 | ||
| 2020-12-16 | Chowdhury Badrul A. CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2020-12-16 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2020-12-16 | McCracken Joseph S Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-12-16 | RAMSAY DAVID A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-12-16 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-12-16 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 13 of 20 · 390 trades